Alnylam announces appointment of peter kellogg to board of directors

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny) the leading rnai therapeutics company, announced today the appointment of peter kellogg to its board of directors. mr. kellogg is an accomplished industry executive with extensive global financial and strategic management experience. “mr.

ALNY Ratings Summary

ALNY Quant Ranking